日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine

在精准医疗时代,探索神经母细胞瘤细胞系和患者来源的肿瘤类器官中的高通量药物敏感性检测

Langenberg, Karin P S; van Hooff, Sander R; Koopmans, Bianca; Strijker, Josephine G M; Kholosy, Waleed M; Ober, Kimberley; Zwijnenburg, Danny A; van der Hoek, Jessica J F; Keller, Kaylee M; Vernooij, Lindy; Schild, Linda G; Looze, Eleonora J; Ebus, Marli E; Essing, Anke H W; Vree, Paula de; Tas, Michelle L; Matser, Yvette A H; Wienke, Judith; Volckmann, Richard; Tops, Bastiaan B J; Kester, Lennart A; Badloe, Shashi; Hehir-Kwa, Jayne Y; Kemmeren, Patrick; Goemans, Bianca F; Zwaan, C Michel; Oehme, Ina; Jäger, Nathalie; Witt, Olaf; van Eijkelenburg, Natasha K A; Dierselhuis, Miranda P; Tytgat, Godelieve A M; Wijnen, Marc H W; van Noesel, Max M; de Krijger, Ronald R; Eising, Selma; Koster, Jan; Dolman, Emmy M; Molenaar, Jan J

Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy.

利用斑马鱼模拟高危儿童癌症,为精准治疗提供信息

Azzam Nadine, Fletcher Jamie I, Melong Nicole, Lau Loretta M S, Dolman Emmy M, Mao Jie, Tax Gabor, Cadiz Roxanne, Tuzi Lissandra, Kamili Alvin, Dumevska Biljana, Xie Jinhan, Chan Jennifer A, Senger Donna L, Grover Stephanie A, Malkin David, Haber Michelle, Berman Jason N

Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells

用于将 Survivin 抑制剂 Sepantronium Bromide (YM155) 靶向递送至神经母细胞瘤肿瘤细胞的抗 GD2 免疫脂质体

Gholizadeh, Shima; Dolman, Emmy M; Wieriks, Rebecca; Sparidans, Rolf W; Hennink, Wim E; Kok, Robbert J